Clene Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Clene Inc. (CLNN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $6.84 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-14
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $37.92, a 611.44% increase year-over-year.
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $5.33, a 8.58% decline year-over-year.
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $5.83, a 1.02% decline year-over-year.
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2022-03-31 was $5.89, a 36.34% increase year-over-year.
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $15.67, a 79.85% decline from fiscal 2024.
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $77.76, a 1326.79% increase from fiscal 2023.
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $5.45, a 0.18% decline from fiscal 2022.
- Clene Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $5.46, a 35.38% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.84 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $15.67 10-K · filed 2026-03-17 | |||
| 2025-09-30 | $31.35 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $31.79 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $37.92 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $77.76 10-K · filed 2025-03-24 | |||
| 2024-09-30 | $88.26 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | $91.99 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $5.33 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $5.45 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $4.51 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $5.43 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $5.83 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | $5.46 10-K · filed 2023-03-13 | |||
| 2022-09-30 | $5.06 10-Q · filed 2022-11-07 | |||
| 2022-06-30 | $5.07 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $5.89 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | $8.45 10-K · filed 2022-03-11 | |||
| 2021-09-30 | $8.66 10-Q · filed 2021-11-08 | |||
| 2021-06-30 | $8.26 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $4.32 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | $1.65 10-K · filed 2021-03-29 | |||
| 2019-12-31 | $1.44 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |